Skip to main content
. 2014 Apr 28;69(8):2164–2174. doi: 10.1093/jac/dku127

Figure 5.

Figure 5.

Effect of single-dose prophylactic treatment using BTA938 for an influenza A/California/04/2009 (H1N1)pdm09 virus infection. Survival and body weight were monitored following a single treatment with 10 mg/kg BTA938 on day −7, −3 or −1 pre-virus challenge. A significant difference in survival, compared with placebo, was observed for all prophylactic treatments (a). However, significant differences in mean body weights were not observed (b). ***P < 0.001.